ABOUT US  |  CAREERS  |  CONTACT US  |  LOGIN  |  SITE MAP  

Recommendations have been developed through the consensus of the Transfusion Medicine Advisory Group (TMAG), which consists of transfusion medicine physicians, technologists and nurses from hospitals across BC. The BC Provincial Blood Coordinating Office, Technical Resource Group and Nursing Resource Group have provided invaluable support for these initiatives. Recognizing the evolution of formalized processes for the development of "guidelines," the latter term was replaced by the term "recommendations" in 2014. Historical document titles are unchanged.

Below is a list of recommendations either developed or endorsed by BC transfusion stakeholders. 

 BC Recommendations
Dated
Cross-Health Authority Transfusion Reaction Recommendation Mar 2024
Guidelines for SCIG Home Infusion Programs Jan 2023
IVIG Utilization Management Program Recommendations July 2019
TMAG Recommendations for O Neg Use in Emergency Transfusions Aug 2018
Hereditary Angioedema Treatment Recommendations Jan 2016 
Recommendations for RBC Transfusion Jun 2014
Guidelines for Albumin Use for Adults in BC Oct 2007

Guidelines for the Use of CMV Seronegative Blood Products

Note: this section is under review to align with the most recent NAC Recommendations endorsed by TMAG

Apr 2007
Guidelines for Implementation of Informed Consent for Blood and Blood Products Apr 1999
BC Endorsed Recommendations Dated
NAC: Recommendations for the Notification of Recipients of a Blood Component Recall July 2023
 TM Medical Policy Manual - Recommendations
Dated

Irradiation of Blood Components - Section 6.2 of the TM Medical Policy Manual

Note: this section is under review to align with the most recent NAC Recommendations endorsed by TMAG

Mar 2015
Technical Recommendations for the Appropriate Use of Blood Components  in Neonates and Infants Less Than 4 Months of Age - Section 8.1 of the TM Medical Policy Manual Jun 2015 
Clinical Recommendations for the Appropriate Use of Blood Components  in Neonates and Infants Less Than 4 Months of Age - Section 8.2 of the TM Medical Policy Manual Jun 2015 
Sickle Cell Recommendations - Section 9.6 of the TM Medical Policy Manual 

Oct 2023